Valuation: Imexpharm Corporation

Market Cap 5,236B 203M 185M 172M 155M 291M 19B 305M 2.07B 823M 10.27B 763M 747M 32.53B P/E 2026 *
14.8x
P/E 2027 * 13.6x
Enterprise Value 5,236B 203M 185M 172M 155M 291M 19B 305M 2.07B 823M 10.27B 763M 747M 32.53B EV / Sales 2026 *
1.97x
EV / Sales 2027 * 1.82x
Free-Float
6.42%
Yield 2026 *
2.94%
Yield 2027 * 2.94%
1 day-1.16%
1 week-4.23%
Current month-5.03%
1 month-4.36%
3 months-8.85%
6 months-27.66%
Current year-35.24%
1 week 33,200
Extreme 33200
34,750
1 month 33,200
Extreme 33200
37,800
Current year 32,650
Extreme 32650
57,000
1 year 32,650
Extreme 32650
57,000
3 years 23,681.82
Extreme 23681.818181
57,000
5 years 18,831.17
Extreme 18831.168829
57,000
10 years 13,036.96
Extreme 13036.963036
57,000
Manager TitleAgeSince
Chief Executive Officer 74 01/08/2001
Director of Finance/CFO 52 18/01/2024
Chief Operating Officer 47 -
Director TitleAgeSince
Chairman 74 01/01/1984
Director/Board Member 51 28/04/2018
Director/Board Member - 30/05/2020
Date Insider Type Main position Quantity % Market Cap. Importance
26/9/22 Buy

Chief Executive Officer

140,000 0.2100%
20/7/22 Sell

Chief Executive Officer

100,000 0.1500%
1/4/22 Exercice

Chairman

50,000 0.0750%
Change 5-day change 1-year change 3-year change Capi.($)
-1.16%-4.23%-28.04%+33.10% 203M
-2.29%-5.34%+28.73%+128.34% 1,204B
-2.04%-5.78%+31.91%+78.34% 643B
-0.86%-3.71%+21.74%+105.02% 501B
-0.14%-1.58%+27.74%+67.95% 378B
-3.61%-9.62%+39.73%+30.53% 327B
+0.52%-4.68%+27.25%+51.61% 285B
+1.07%-3.78%-1.44%+33.13% 270B
-1.14%-6.05%+28.16%+65.35% 237B
-1.45%-0.85%+30.03%+120.72% 207B
Average -0.12%-4.18%+20.58%+71.41% 405B
Weighted average by Cap. +0.08%-4.71%+27.08%+88.16%

Financials

2026 *2027 *
Net sales 2,659B 103M 94.14M 87.14M 78.82M 148M 9.65B 155M 1.05B 418M 5.21B 388M 380M 16.52B 2,881B 112M 102M 94.42M 85.4M 160M 10.46B 168M 1.14B 453M 5.65B 420M 411M 17.9B
Net income 394B 15.31M 13.95M 12.91M 11.68M 21.91M 1.43B 22.93M 156M 61.91M 773M 57.44M 56.23M 2.45B 428B 16.63M 15.15M 14.03M 12.69M 23.8M 1.55B 24.91M 170M 67.26M 839M 62.39M 61.09M 2.66B
Net Debt - -
Projected Income Statement - Annual - Imexpharm Corporation
Logo Imexpharm Corporation
Imexpharm Corporation is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. It is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.
Employees
1,453
Date Price Change Volume
19/11/26 ₫34,000.00 -1.16% 2,723
18/11/26 ₫34,400.00 -0.72% 2,703
17/11/26 ₫34,650.00 -0.14% 4,455
16/11/26 ₫34,700.00 -0.14% 3,143
13/11/26 ₫34,750.00 -2.11% 1,620
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
34,000.00VND
Average target price
56,000.00VND
Spread / Average Target
+64.71%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Imexpharm Corporation